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Abstract
Bioelectrical impedance analysis (BIA) is an inexpensive, quick and non-invasive method to determine body composition. Equations used in BIA are typ-
ically derived in healthy individuals of European descent. BIA is speciﬁc to health status and ethnicity and may therefore provide inaccurate results in
populations of different ethnic origin and health status. The aim of the present study was to test the validity of BIA in Ethiopian antiretroviral-naive
HIV patients.
BIA was validated against the 2H dilution technique by comparing fat-free mass (FFM) measured by the two methods using paired t tests and Bland–
Altman plots. BIA was based on single frequency (50 kHz) whole-body measurements. Data were obtained at three health facilities in Jimma Zone, Oromia
Region, South-West Ethiopia. Data from 281 HIV-infected participants were available. Two-thirds were female and the mean age was 32·7 (SD 8·6) years.
Also, 46 % were underweight with a BMI below 18·5 kg/m2. There were no differences in FFM between the methods. Overall, BIA slightly underesti-
mated FFM by 0·1 kg (−0·1, 95 % CI −0·3, 0·2 kg). The Bland–Altman plot indicated acceptable agreement with an upper limit of agreement of 4·5 kg
and a lower limit of agreement of −4·6 kg, but with a small correlation between the mean difference and the average FFM. BIA slightly overestimated FFM
at low values compared with the 2H dilution technique, while it slightly underestimated FFM at high values. In conclusion, BIA proved to be valid in this
population and may therefore be useful for measuring body composition in routine practice in HIV-infected African individuals.
Key words: Bioelectrical impedance analysis: Body composition: HIV: African population
Malnutrition is common in individuals infected with HIV in
sub-Saharan Africa. Chronic infections such as HIV result in
immune impairment which leads to malnutrition, causing fur-
ther immune impairment and thereby a more rapid disease
progression. On the other hand, malnourished individuals
have increased susceptibility to HIV and opportunistic infec-
tions, and are thereby more likely to have a faster disease pro-
gression compared with well-nourished individuals(1).
The wasting syndrome in HIV is characterised by weight
loss often accompanied by chronic diarrhoea or chronic weak-
ness and fever(2). It has been one of the main characteristics of
HIV and it is still a common complication in the antiretroviral
therapy (ART) era(3). In HIV-infected individuals starting
ART, malnutrition may be an independent predictor of early
mortality(4). Measurement of body composition is an import-
ant tool to assess effects of weight loss and therefore it is
Abbreviations: ART, antiretroviral therapy; BIA, bioelectrical impedance analysis; FFM, fat-free mass; FM, fat mass.
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crucial to ﬁnd an easy, quick and valid method to determine
body composition.
Bioelectrical impedance analysis (BIA) is an inexpensive,
non-invasive and easy-to-use method to determine body com-
position(5). The most widely used approach predicts values for
total body water, allowing calculation of fat-free mass (FFM)
and fat mass (FM). Total body water predictions are typically
calibrated using data from a healthy reference population,
often of white European descent, using a reference method
such as dual-energy X-ray absorptiometry and regression for-
mulae that include height and impedance as variables, but
often also other terms such as age, weight and sex(5). The
hydration of FFM is considered relatively constant through
adulthood in healthy individuals(6), but several illnesses and
conditions such as HIV and malnutrition are associated with
weight loss and thereby alter body composition(7), potentially
also affecting hydration.
Additionally, the manufacturers’ equations used in BIA are
typically derived in individuals of European descent(8). Several
validation studies using the 2H dilution technique as the refer-
ence method have concluded that BIA was a valid method to
determine body composition in HIV-infected individuals(9,10).
One of the studies was conducted in an American cohort and
included black Americans(9). The other study was conducted
in Europe based on data from a small sample(10). However,
the accuracy of these equations, when used in African HIV-
infected individuals has subsequently been questioned(11).
Therefore, equations used in BIA based on healthy subjects
of European descent may provide inaccurate results in
Africans with HIV.
The aim of the present study was to test the validity of BIA
for the assessment of FFM in ART-naive Ethiopian HIV-
infected patients.
Methods
Study design and population
This study used baseline data from the ARTfood study(12),
which was a randomised controlled trial investigating the
effects and feasibility of providing a lipid-based nutrient sup-
plement in HIV-infected patients at initiation of ART. The
sample size was calculated for the primary outcome of the
trial.
Participants were recruited among HIV patients eligible for
ART and took place at Jimma University Specialised Hospital,
and health centres in Jimma and Agaro. The inclusion criteria
for the ARTfood study were ≥18 years, BMI ≥16 kg/m2,
ART-naive, eligible for initiation of ART, and living within
50 km of the recruitment facility. Patients were excluded if
they were pregnant, lactating, taking micronutrients or other
nutrient supplementation. Patients with BMI <16 kg/m2
were invited for data collection and therefore included in
this study, whereas they were excluded from intervention
and referred to standard nutritional therapy according to
national guidelines(13).
Eligibility of ART during the study was based on the
Ethiopian treatment guidelines from 2008. HIV patients
were eligible if they had CD4 count ≤200 cells/μl irrespective
of clinical symptoms, CD4 count ≤350 cells/μl if WHO stage
III, or WHO stage IV irrespective of CD4 count(14).
Data collection
The study staff included nurses, laboratory technicians and
pharmacists, all receiving relevant training. Data collection
was carried out from July 2010 to July 2013.
Background data
Background data were collected through structured question-
naires in the local languages Amharic or Afaan Oromo. For
the present study, data on age, sex, education and occupation
were used.
Anthropometric data
For height and weight measurements, participants were bare-
foot and wearing light clothes. A calibrated stadiometer
(SECA 214 Stadiometer) and scale (Tanita-BC 418 MA) were
used for height and weight, respectively. Weight was measured
with 0·1 kg precision and height to the nearest 1 mm. BMI was
calculated as weight divided by squared height (kg/m2) and
categorised as <16·0, 16·0–<17·0, 17·0–<18·5, 18·5–25·0 or
>25·0 kg/m2 according to WHO classiﬁcation(15).
HIV status
Information regarding clinical stage of HIV using WHO
criteria(16) was extracted from patient records and checked
by a study clinician. CD4 cell count was determined in
EDTA-stabilised whole blood using ﬂow cytometry
(Fascount; Becton Dickinson) and categorised into <50, 50–
<100, 100–200 and >200 cells/μl for analyses. To determine
viral load, plasma was kept at −80°C before quantiﬁcation of
HIV-1 viral load using a commercial real-time PCR assay
(RealTimeHIV-1; Abbott Laboratories) with automated
extraction (M2000 Real Time System, Abbott Laboratories).
HIV viral load was categorised as <4, 4–5 and >5 log
(1 + copies/ml)(17).
2H dilution technique
Body composition was assessed with 30 g 2H-labelled water
(99·8 % 2H; Sercon) weighed with 0·01 g precision and
given orally after collection of pre-dose saliva samples.
Post-dose saliva samples were collected after 4 h equilibra-
tion(18). Saliva enrichment of 2H was determined by a
Fourier transform infrared spectrometer (IRAfﬁnity-1;
Shimadzu). Total body water was calculated from post-dose
2H enrichment with adjustment for pre-dose enrichment,
using a factor of 1·041 to adjust for proton exchange. FFM
was calculated based on an assumed hydration factor of
73·2 %(18). FM was thereafter calculated by subtracting FFM
from total body weight(18).
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Bioelectrical impedance analysis
Body composition was also measured using single-frequency
eight-electrode BIA (Tanita-BC 418 MA). Participants were
barefoot, wearing light clothes and asked to empty pockets
and remove any metal objects. The Tanita body composition
analyser measures body composition using a constant current
source at a frequency of 50 kHz and provides impedance (Z )
measured in ohms. Fat percentage, FM and FFM are pro-
duced by regression algorithms generated by the manufacturer,
the details of which are not available, though it is described
that the algorithms are based on data from ‘Western’ and
Japanese individuals(19). BIA assessment was available for all
participants recruited at Jimma University Specialised
Hospital and the health centre in Jimma, but for logistic rea-
sons only for some of the participants attending the health
centre in Agaro.
Data analysis
The collected data were double-entered and validated using
Epidata (EpiData Association, Denmark). Data analyses
were carried out using STATA/IC version 13.0 (StataCorp
LLC). FFM was used as the primary outcome to compare
BIA against the 2H dilution technique. Paired t tests were
used to compare FFM measured by the two different meth-
ods. Overall two paired t tests were conducted. The ﬁrst test
was stratiﬁed by sex and age group (18–<30, 30–<40 and
>40 years). The second test was stratiﬁed by CD4 cell count
including <50, 50–<100, 100–200 and >200 cells/μl. Values
in the tables are mean values and standard deviations for
FFM and mean differences (95 % CI). P values <0·05 were
considered signiﬁcant.
The Bland–Altman plot was used to evaluate agreement
between FFM measured by BIA and the 2H dilution tech-
nique. Furthermore, regression models were conducted for
FFM and FM to test if there were correlations between the
mean difference and average by the two methods.
Additionally, a calibration equation was generated from our
own data. The participants were equally divided into two ran-
dom samples using a random sampling generator (STATA/IC
version 13; StataCorp LLC). One sample was used to develop
the equation through multiple linear regression for prediction
of FFM as measured by the 2H dilution technique. The mul-
tiple regression model included impedance index (HT2/z),
weight, age and sex as predictors. The other sample was
used to test the predictive ability of the equation using limits
of agreement. The predicted FFM was tested against FFM
as measured by BIA and the 2H dilution technique,
respectively.
Results
Of 453 HIV-infected patients screened between July 2010 and
August 2012, 348 (77 %) were recruited for the ARTfood
study. Participants were younger (32·9 v. 37·0 years; P=
0·001) and had lower education (21 v. 45 % with secondary
school or higher; P< 0·001) than those not recruited, while
BMI and other demographic characteristics were similar(20).
The 2H dilution technique was used for the primary outcome
of the trial and the Tanita body composition analyser was not
available at all sites. Of the recruited participants, data from
both BIA and the 2H dilution technique were available in
281 (81 %) participants and therefore included in the present
validation study.
Characteristics of the 281 HIV-infected participants are
shown in Table 1. Two-thirds (68 %) of the participants
were female and the mean age was 32·7 (SD 8·6) years.
There was a high prevalence of underweight, as almost half
(46 %) of the participants had BMI <18·5 kg/m2.
Mean CD4 count was 196·2 (SD 116) cells/μl and 57 % of the
participants had≤ 200 CD4 cells/μl. More than 40 % had viral
load >5 log (1 + copies/ml) and more than two-thirds (71 %)
were symptomatic (i.e. in WHO clinical stage II, III or IV).
There were no signiﬁcant differences between the two meth-
ods. The overall mean FFM measured by BIA was 39·5 kg,
whereas the overall mean FFM measured by the 2H dilution
technique was 39·6 kg. The mean difference between these
two methods was −0·1 (95 % CI −0·3, 0·2) kg. For males,
the mean FFM was 46·2 kg when assessed by BIA and
46·3 kg when assessed by the 2H dilution technique with a
mean difference of −0·2 (95 % CI −0·7, 0·4) kg (Table 2).
For females, the mean FFM was 36·3 kg when assessed by
BIA and 36·4 kg when assessed by the 2H dilution technique
with a mean difference of −0·0 (95 % CI −0·3, 0·3) kg.
Among those with CD4 count <50 cells/μl, the mean differ-
ence was 1·3 kg (P= 0·06) (Table 3).
Fig. 1 shows the Bland–Altman plot of FFM measured by
the 2H dilution technique and BIA using Tanita including
the regression line of the mean difference and average for
FFM. BIA underestimated the 2H dilution technique with a
mean difference of −0·1 (SD 2·3) kg between the two meth-
ods. These data correspond to an upper limit of agreement
of 4·5 kg and a lower limit of agreement of −4·6 kg.
Therefore, since the differences between the methods were
normally distributed (data not shown), 95 % of the differences
are expected to lie between −4·6 and 4·5 kg. The regression
model for FFM showed a small correlation of −0·1 (SE
0·02) (P = 0·01) between the mean difference and the average
and with an R2 of 0·02. For an average FFM of 28 kg, the
regression line predicted a mean difference of 0·6 kg, whereas
the predicted mean difference was −1·2 kg for an average
FFM of 58 kg. There was no correlation (P > 0·05) between
the mean difference and the average for FM (data not shown).
The total sample (n 281) was randomised into two subsam-
ples. One was used to develop a predictive equation (equation
sample) and the other to validate the equation (validation sam-
ple). There were no signiﬁcant differences in characteristics
between the two subsamples (data not shown). Based on
data from the equation sample, FFM by the 2H dilution tech-
nique was predicted by the following equation:
FFM2H = 18·74+ 0·20×HT
2
Z
( )
+ 0·42× weight( )
− 0·07× age( )− 6·24× female sex( ),
3
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where height (HT) is in cm, Z is in ohms, weight is in kg, age is
in years, and female sex is a dummy variable (R2 0·82; stand-
ard error of estimate 2·6 kg).
The predicted FFM was tested in the validation sample
against Tanita and resulted in a mean difference of −0·1 (SD
2·2) kg and an upper limit of agreement of 4·3 kg and a
lower limit of agreement of −4·5 kg. The predicted FFM
tested against the 2H dilution technique resulted in a mean dif-
ference of −0·1 (SD 2·9) kg and an upper limit of agreement of
−5·8 kg and a lower limit of agreement of 5·6 kg.
Discussion
In this cohort, we compared BIA by the Tanita body compos-
ition analyser against the reference method of 2H dilution for
determining FFM in Ethiopian HIV-infected individuals.
There were no differences between FFM measured by the
two methods neither in the comparison stratiﬁed by age and
sex, nor in the comparison stratiﬁed by CD4 cell count. In
the strata <50 CD4 cells/μl and males aged 18–29 years,
there were relatively few participants with n 18 in the ﬁrst
and n 14 in the latter. These small subgroups may have caused
type II error, potentially failing to detect a difference between
FFM measured by BIA and the 2H dilution technique.
The Bland–Altman plot also indicated acceptable agreement
between the two methods with a small mean difference and
limits of agreements similar to other BIA studies in
adults(11,21). However, there was a small correlation between
the mean difference and the average FFM with an R2 value
of 0·02 indicating that 2 % of the variance in the mean differ-
ence was due to the level of FFM. The regression line indi-
cated that BIA slightly overestimated the 2H dilution
technique at low FFM, while it underestimated at high FFM
values. Nonetheless, these differences are considered minimal.
CD4 cell count is an indicator of health status and disease
progression in HIV-infected individuals. Healthy individuals
have a CD4 cell count between 500 and 1600 cells/μl(22). In
the present study, approximately 60 % of the HIV-infected
participants had a CD4 cell count <200 cells/μl, which is con-
sidered very low. In this cohort, very low CD4 cell count did
not seem to affect validity of BIA signiﬁcantly. Further
research is needed to validate BIA against the 2H dilution tech-
nique especially in severely ill HIV-infected individuals with a
CD4 cell count <50 cells/μl.
HIV-infected individuals may vary in hydration of FFM
during the different stages of the disease, caused either by
dehydration or ﬂuid retention which may inﬂuence bioelec-
trical resistance in the body and thereby affect the accuracy
of BIA measurements(11). However, this problem will also
affect results of the 2H dilution technique, which also assumes
constant hydration. Equations for BIA measurement derived
and validated by Kotler et al. in a cohort of white, black and
Hispanic HIV-infected and uninfected individuals(9) were
reported as not valid in another study in an African HIV-
infected cohort(11). Surprisingly, among the ﬁfteen published
equations they tested, the two equations they found valid in
their HIV-infected cohort were developed in uninfected indi-
viduals(11). This is in accordance with the present study where
the manufacturer’s equation was developed based on data
from uninfected individuals.
When using BIA to measure body composition, besides
health status and ethnicity, other considerations need to be
taken into account. These include potential intra-individual
variability in hydration due to shifts in ﬂuids and
Table 1. Characteristics of antiretroviral therapy-naive individuals infected
with HIV
(Numbers of subjects and percentages or mean values and standard
deviations)
HIV positive (n 281)
n %
Background characteristics
Age (years)
Mean 32·7
SD 8·6
Female 190 67·6
Education
No formal schooling* 70 24·9
Primary† 144 51·3
Secondary or higher‡ 67 23·8
Occupation
Small-scale trader/merchant 32 11·4
Formal job sector public/private 68 24·2
Informal daily labourer/farmer, etc. 79 28·1
Unemployed/housewife 87 31·0
Other 15 5·3
Anthropometric characteristics
Height (cm)
Mean 160·4
SD 8·3
Weight (kg)
Mean 49·3
SD 7·9
BMI (kg/m2)§
<16 23 8·2
16·0–16·9 30 10·7
17·0–18·49 76 27·1
18·5–24·9 144 51·3
>25 8 2·9
Fat-free mass (kg)‖
Mean 39·5
SD 6·4
Fat mass (kg)‖
Mean 9·7
SD 5·0
HIV status
CD4 count (cells/μl)
<50 18 6·6
50–100 36 13·2
100–200 101 37·0
>200 118 43·2
Viral load, log (1 + copies/ml)
<4 45 16·5
4–5 112 41·0
>5 116 42·5
WHO stage
Stage I 80 29·0
Stage II 78 28·3
Stage III 92 33·3
Stage IV 26 9·4
* No formal schooling/only able to read and write.
†Some primary school/finished primary school.
‡ Finished secondary school/attended higher education.
§ BMI was classified according to the WHO classification, which is the International
Classification of adult underweight, overweight and obesity according to BMI(15).
‖Measured using the 2H dilution technique.
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electrolytes(23). Intra-individual variability can be divided into
inter-day changes and intra-day ﬂuctuations which cause
changes in impedance. Changes in impedance of the trunk
are very small, whereas impedance changes in the upper and
lower limbs are much bigger. Intra-day variability in water con-
tent and distribution is due to consumption of food and phys-
ical activity(19), but could also be due to changes in disease
status. Inter-day changes are caused by temporary weight
changes, for example caused by dehydration, over-eating
and/or -drinking(19). It is therefore important to register and
control for behaviour that may change hydration before
using the BIA method(23).
Ethnicity has also been shown to affect the accuracy of BIA,
especially in African populations. The validity of BIA equa-
tions regarding ethnicity remains uncertain, as some equations
have shown validity, while other equations show under- or
over-estimation of BIA measurements against the reference
method(24). This may be due to differences in length of
limbs and body composition. For example, African individuals
generally have longer legs than European individuals, while
Asian individuals are known to have shorter legs(8). This is
relevant in BIA because impedance is unequally distributed
across regional anatomy and thereby overestimation of FM
may occur if the population generally has longer legs than
those used in the equations of the BIA method(8). However,
in this cohort African ethnicity did not seem to affect BIA val-
idity despite the fact that the equations in the BIA were based
on data from ‘Western’ and Japanese individuals(19). A possible
explanation is that Ethiopian individuals may have body geom-
etry more similar to the reference population than the general
African population. Another possible explanation is that the
combination of ‘Western’ and Japanese individuals used as
the reference population in the equations used by Tanita
resulted in valid measurements.
The overall t test and the Bland–Altman plot showed a
mean difference of −0·1 (SD 2·3) kg with BIA slightly, but
Table 2. Comparison of fat-free mass measured through the 2H dilution technique v. bioelectrical impedance analysis (BIA) in HIV-infected individuals
stratified by age group and sex*
(Mean values and standard deviations)
Fat-free mass BIA Fat-free mass 2H dilution
Age group Participants (n) Mean SD Mean SD Difference 95% CI P
Males† 92 46·2 5·2 46·3 5·1 −0·2 −0·7, 0·4 0·58
18–29 years 14 45·0 5·6 44·9 5·4 0·2 −1·2, 1·6 0·77
30–39 years 43 47·8 5·4 47·5 5·5 0·3 −0·4, 1·0 0·46
>40 years 35 44·6 4·5 45·4 4·3 −0·8 −2·0, 0·3 0·16
Females‡ 189 36·3 3·1 36·4 4·0 −0·0 −0·3, 0·3 0·82
18–29 years 94 36·5 2·9 36·5 4·1 −0·0 −0·4, 0·4 0·97
30–39 years 71 36·2 2·9 36·4 3·6 −0·2 −0·7, 0·2 0·37
>40 years 24 36·1 4·2 35·7 4·9 0·4 −0·5, 1·3 0·38
* Fat-free mass measured through the 2H dilution technique and BIA by the Tanita body composition analyser was compared using paired t tests.
†All HIV-infected male participants with BIA and 2H dilution data.
‡All HIV-infected female participants with BIA and 2H dilution data.
Table 3. Comparison of fat-free mass from the 2H dilution technique and fat-free mass measured using bioelectrical impedance analysis (BIA) in
HIV-infected individuals stratified by CD4 cell count*
(Mean values and standard deviations)
Fat-free mass BIA Fat-free mass 2H dilution
CD4 cell count Participants (n) Mean SD Mean SD Difference 95% CI P
All† 281 39·5 6·1 39·6 6·4 −0·1 −0·3, 0·2 0·58
<50 cells/μl 18 39·9 6·5 38·6 5·7 1·3 −0·0, 2·6 0·06
50–100 cells/μl 37 39·8 6·0 40·2 6·3 −0·4 −1·1, 0·2 0·19
100–200 cells/μl 103 39·6 6·0 39·8 6·7 −0·1 −0·6, 0·3 0·52
>200 cells/μl 123 39·4 6·1 39·5 6·4 −0·1 −0·5, 0·3 0·62
* Fat-free mass measured through the 2H dilution technique and BIA by the Tanita body composition analyser was compared using paired t tests.
†All HIV-infected participants with BIA and 2H data.
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Fig. 1. Bland–Altman plot including regression line of difference v. mean,
comparing fat-free mass measured by the 2H dilution technique and bioelec-
trical impedance analysis (BIA).
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not signiﬁcantly, underestimating FFM compared with the 2H
dilution technique. The small correlation detected between
mean difference and average FFM by the two methods reveals
that there was a negligible difference when using BIA com-
pared with the 2H dilution technique in this population.
Measuring FFM using the Tanita body composition analyser
resulted in an error of ±4·6 kg (1·96 SD limits of agreement)
in this population. This accuracy is typical for BIA in
adults(21,24). Furthermore, a standard error of estimate of 2·3
in women and 3·0 in men has been reported as ‘very good per-
formance’(25). We therefore consider this accuracy of BIA clin-
ically acceptable.
Using our own data, we could predict FFM from the imped-
ance index, age, weight and sex with an error of ±5·2 kg (1·96
SD limits of agreement). This is only slightly less accurate than
published predictions using data from healthy African popula-
tions(21). Since all information is known, it would be valuable
to conduct further validation using more parameters. It may be
preferable to predict total body water instead of FFM to make
it more comparable with other published equations.
The main strength of the present study is that it used the 2H
dilution technique as the reference method, because it is charac-
terised with high accuracy and precision(26). Another strength is
the large number of participants. It is also a strength that the
majority of the participants had poor health status and pro-
gressed HIV infection (CD4 count <200 CD4 cells/μl), because
they are likely to differentiate more from healthy individuals
than HIV-infected individuals with a better health status.
However, it may be a limitation that the sample was not rep-
resentative of HIV patients. The HIV-infected patients were
included at ART initiation, based on criteria of the 2008 guide-
line, and all of them had a low CD4 count or were symptom-
atic. Therefore, the variety in disease severity was small.
Another limitation is the potential type II error in the strata
<50 CD4 cells/μl and males aged 18–29 years. The fact that
BIA measurements were not available for all participants
may also be a limitation. Nonetheless, missing data were due
to limitations in logistics and therefore not expected to be
associated with outcome. It should be noted that the Tanita
body composition analyser validated in this study is a discon-
tinued model and the replaced model uses a different
algorithm.
In conclusion, the Tanita body composition analyser is con-
sidered a valid tool for the assessment of FFM in this cohort
of Ethiopian ART-naive HIV patients. BIA is an easy and
inexpensive method to determine body composition and
according to the results from this study it was reliable in
both males and females in all age groups and also in all
CD4 strata. BIA may therefore be a useful method to measure
body composition in routine clinical and epidemiological prac-
tice in HIV-infected African individuals.
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